Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10990-10994

  McSharry, Brian P ^a   Forbes, Simone K ^a,b   Cao, John Z ^a,b   Avdic, Selmir ^a   Machala, Emily A ^a   Gottlieb, David J ^a,b   Abendroth, Allison ^a   Slobedman, Barry ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ECALECTIN; MESSENGER RNA; GALECTIN; LGALS9 PROTEIN, HUMAN;

ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; VIRUS GENE; VIRUS REACTIVATION; CYTOMEGALOVIRUS; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIROLOGY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GALECTINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; UP-REGULATION;

EID: 84906342303     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01259-14     Document Type: Article

References (27)

1. Slobedman B, Cao JZ, Avdic S, Webster B, McAllery S, Cheung AK, Tan JC, Abendroth A. 2010. Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol. 5:883-900. http: //dx.doi.org/10.2217/fmb.10.58.
2. Griffiths PD. 2012. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect. Dis. 12:790-798. http://dx.doi.org/10.1016/S1473-3099(12)70197-4.
3. Wiersma VR, de Bruyn M, Helfrich W, Bremer E. 2013. Therapeutic potential of galectin-9 in human disease. Med. Res. Rev. 33(Suppl 1): E102-E126. http://dx.doi.org/10.1002/med.20249.
4. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6:1245- 1252. http://dx.doi.org/10.1038/ni1271.
5. Su EW, Bi S, Kane LP. 2011. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology 21:1258-1265. http://dx.doi.org /10.1093/glycob/cwq214.
6. Elahi S, Niki T, Hirashima M, Horton H. 2012. Galectin-9 binding to Tim-3 renders activated human CD4_ T cells less susceptible to HIV-1 infection. Blood 119:4192-4204. http://dx.doi.org/10.1182/blood-2011 -11-389585.
7. Bi S, Hong PW, Lee B, Baum LG. 2011. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc. Natl. Acad. Sci. U. S. A. 108:10650- 10655. http://dx.doi.org/10.1073/pnas.1017954108.
8. Sharma S, Sundararajan A, Suryawanshi A, Kumar N, Veiga-Parga T, Kuchroo VK, Thomas PG, Sangster MY, Rouse BT. 2011. T cell immunoglobulin and mucin protein-3 (Tim-3)/galectin-9 interaction regulates influenzaAvirus-specific humoral andCD8T-cell responses. Proc. Natl. Acad. Sci. U. S. A. 108:19001-19006. http://dx.doi.org/10.1073/pnas.1107087108.
9. Sehrawat S, Reddy PB, Rajasagi N, Suryawanshi A, Hirashima M, Rouse BT. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memoryCD8T cell response. PLoS Pathog. 6:e1000882. http: //dx.doi.org/10.1371/journal.ppat.1000882.
10. Klibi J, Niki T, Riedel A, Pioche-Durieu C, Souquere S, Rubinstein E, Le Moulec S, Guigay J, Hirashima M, Guemira F, Adhikary D, Mautner J, Busson P. 2009. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113:1957-1966. http://dx.doi.org/10 .1182/blood-2008-02-142596.
11. Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquere S, Nishi N, Hirashima M, Middeldorp J, Busson P. 2006. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6:283. http://dx.doi.org/10.1186/1471-2407-6-283.
12. Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, Seirafian S, McSharry BP, Neale ML, Davies JA, Tomasec P, Davison AJ, Wilkinson GW. 2010. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J. Clin. Invest. 120:3191-3208. http://dx.doi.org/10 .1172/JCI42955.
13. Cheung AK, Abendroth A, Cunningham AL, Slobedman B. 2006. Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108:3691-3699. http://dx .doi.org/10.1182/blood-2005-12-026682.
14. Taylor RT, Bresnahan WA. 2006. Human cytomegalovirus immediateearly 2 protein IE86 blocks virus-induced chemokine expression. J. Virol. 80:920-928. http://dx.doi.org/10.1128/JVI.80.2.920-928.2006.
15. Heusschen R, Griffioen AW, Thijssen VL. 2013. Galectin-9 in tumor biology: a jack of multiple trades. Biochim. Biophys. Acta 1836:177-185. http://dx.doi.org/10.1016/j.bbcan.2013.04.006.
16. Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Abedin MJ, Yoshida N, Nishi N, Imaizumi T, Saita N, Toyama Y, Takashima H, Nakamura T, Ohkawa M, Hirashima M. 2002. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J. Immunol. 169:5912-5918. http://dx.doi.org/10.4049/jimmunol.169.10.5912.
17. Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Nishi N, Fujimoto K, Tanji K, Shibata T, Tamo W, Matsumiya T, Yoshida H, Cui XF, Takanashi S, Hanada K, Okumura K, Yagihashi S, Wakabayashi K, Nakamura T, Hirashima M, Satoh K. 2002. Interferongamma stimulates the expression of galectin-9 in cultured human endo- thelial cells. J. Leukoc. Biol. 72:486-491. http://www.jleukbio.org/content /72/3/486.long.
18. Alam S, Li H, Margariti A, Martin D, Zampetaki A, Habi O, Cockerill G, Hu Y, Xu Q, Zeng L. 2011. Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3. J. Biol. Chem. 286:44211-44217. http://dx.doi.org/10.1074/jbc.M111.242289.
19. Hilton L, Moganeradj K, Zhang G, Chen YH, Randall RE, McCauley JW, Goodbourn S. 2006. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J. Virol. 80:11723-11732. http://dx.doi.org/10 .1128/JVI.01145-06.
20. Andrejeva J, Young DF, Goodbourn S, Randall RE. 2002. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76:2159- 2167. http://dx.doi.org/10.1128/jvi.76.5.2159-2167.2002.
21. Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A, Yi T, Williams BR, Borden EC. 2003. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFNbeta compared with IFN-alpha2. J. Interferon Cytokine Res. 23:745-756. http://dx.doi.org/10.1089/107999003772084860.
22. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, Mc-Williams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR. 2010. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One 5:e9504. http://dx.doi.org/10 .1371/journal.pone.0009504.
23. Chagan-Yasutan H, Ndhlovu LC, Lacuesta TL, Kubo T, Leano PS, Niki T, Oguma S, Morita K, Chew GM, Barbour JD, Telan EF, Hirashima M, Hattori T, Dimaano EM. 2013. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J. Clin. Virol. 58:635-640. http://dx.doi.org/10.1016/j.jcv.2013.10 .022.
24. Katoh S, Ikeda M, Shimizu H, Mouri K, Obase Y, Kobashi Y, Fukushima K, Hirashima M, Oka M. 2014. Increased levels of plasma galectin-9 in patients with influenza virus infection. Tohoku J. Exp. Med. 232: 263-267. http://dx.doi.org/10.1620/tjem.232.263.
25. Gooden MJ, Wiersma VR, Samplonius DF, Gerssen J, van Ginkel RJ, Nijman HW, Hirashima M, Niki T, Eggleton P, Helfrich W, Bremer E. 2013. Galectin-9 activates and expands human T-helper 1 cells. PLoS One 8:e65616. http://dx.doi.org/10.1371/journal.pone.0065616.
26. Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, Cooley SA, Verneris MR, Cichocki F, Holman CJ, Panoskaltsis-Mortari A, Niki T, Hirashima M, Blazar BR, Miller JS. 2012. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 119:3064-3072. http://dx.doi.org /10.1182/blood-2011-06-360321.
27. Golden-Mason L, McMahan RH, Strong M, Reisdorph R, Mahaffey S, Palmer BE, Cheng L, Kulesza C, Hirashima M, Niki T, Rosen HR. 2013. Galectin-9 functionally impairs natural killer cells in humans and mice. J. Virol. 87:4835-4845. http://dx.doi.org/10.1128/JVI.01085-12.